Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study-Reference-Cited by-同舟云学术

Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study

Published:2017-03 Issue:3 Volume:17 Page:313-321
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Suzuki Motoi,Dhoubhadel Bhim Gopal,Ishifuji Tomoko,Yasunami Michio,Yaegashi Makito,Asoh Norichika,Ishida Masayuki,Hamaguchi Sugihiro,Aoshima Masahiro,Ariyoshi Koya,Morimoto Konosuke

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference30 articles.

1. Clinical and economic burden of community-acquired pneumonia among adults in Europe;Welte;Thorax,2012

2. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review;Peto;Trans R Soc Trop Med Hyg,2014

3. Community-acquired pneumonia requiring hospitalization among U.S. adults;Jain;N Engl J Med,2015

4. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques;Said;PLoS One,2013

5. The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study;Morimoto;PLoS One,2015

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18–49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study;Vaccines;2024-07-23

2. Follow-Up Study of Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against All-Type and Serotype-Specific Invasive Pneumococcal Disease, Denmark;Emerging Infectious Diseases;2024-06

3. Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan;Expert Review of Vaccines;2024-05-09

4. Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults;Infectious Diseases and Therapy;2024-05-03

5. Nasal Staphylococcus aureus Carriage and Antimicrobial Resistance Profiles Among Community-Dwelling Adults in Jiangsu, China;Infectious Diseases and Therapy;2024-05-03